Clinical Trial Update: Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Rebamipide (regular and nanoparticulated forms) to Clobetasol for methotrexate-induced oral ulceration in rheumatoid arthritis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Clobetasol (clobetasol)
• Rebamipide (nanoparticulated) (rebamipide)
• Rebamipide (regular) (rebamipide)

Snippet

Sponsor: Cairo University | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN